Bellevue Group’s Viridian Therapeutics VRDN Stock Holding History

Bellevue Group’s Portfolio VRDN Stock Details VRDN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$136M	Buy
2024 Q2	–	Sell
2024 Q1	$334K	Sell
2023 Q4	$653K	Sell
2023 Q3	$978K	Buy
2023 Q2	$1.06M	Sell
2023 Q1	$1.17M	Hold
2022 Q4	$1.35M	Hold
2022 Q3	$946K	Sell
2022 Q2	$567K	Buy